Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and overall survival. In triple negative (TN) and HER2-positive breast cancer (BC), the pCR rate exceeds 60 %. Patients with TN and HER2-positive BC w...
Saved in:
Main Authors: | P. V. Krivorotko (Author), V. V. Mortada (Author), R. S. Pesotskiy (Author), A. S. Artemyeva (Author), A. S. Emelyanov (Author), S. S. Ereshchenko (Author), G. A. Dashyan (Author), N. S. Amirov (Author), T. T. Tabagua (Author), L. P. Gigolaeva (Author), A. V. Komyakhov (Author), K. S. Nikolaev (Author), M. M. Mortada (Author), K. Yu. Zernov (Author), E. K. Zhiltsova (Author), V. O. Smirnova (Author), Ya. I. Bondarchuk (Author), D. A. Enaldieva (Author), S. N. Novikov (Author), E. A. Busko (Author), A. V. Chernaya (Author), P. I. Krzhivitskiy (Author), R. M. Paltuev (Author), T. Yu. Semiglazova (Author), V. F. Semiglazov (Author), A. M. Belyaev (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
by: D. A. Enaldieva, et al.
Published: (2023) -
Intraoperative evaluation of the resection margin with the usage of digital two-point sectorography (Faxitron PathVision)
by: Ya. I. Bondarchuk, et al.
Published: (2023) -
Twenty-year experience of examining biopsies of signal lymph nodes in breast cancer
by: V. F. Semiglazov, et al.
Published: (2020) -
Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases
by: G. A. Dashyan, et al.
Published: (2016) -
General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)
by: V. F. Semiglazov, et al.
Published: (2015)